The NCRI Molecular Biomarkers Advisory Group

The role of the Molecular Biomarkers Advisory Group is to provide ad hoc advice on biomarkers in late phase clinical trials to CSGs and others. Specifically, members of this virtual group provide advice for trials involving biomarkers and conduct peer-reviews of the biomarker component of trials.

Chair

Craig Robson
Professor Craig Robson

List of members

Professor Roz Banks
Dr Maggie Cheang
Dr Aled Clayton
Dr Eithne Costello-Goldring
Dr Michael Kemp
Dr Hector Keun
Professor Thomas Powles
Professor Jacqui Shaw
Professor Valerie Speirs
Professor Gareth Thomas

Members also consultant with a wider panel of experts who provide further expertise when required.

Areas of expertise:

  • Tissue and Biofluid sample collection
  • Standard Operating Procedures
  • Histochemistry
  • Circulating Tumour Cells
  • Cell free DNA
  • Exosomes
  • Epigenetic markers (including DNA methylation)
  • Non-coding RNAs
  • Transcriptome
  • Serum Proteomics
  • Targeted sequencing
  • Autoantigens
  • Metabolomics
  • Pharmacodynamic/Pharmacokinetic markers
  • Bioinformatics/Biostatistics.

Those seeking advice from the Molecular Biomarkers Advisory Group with regards to a specific study should complete the NCRI Study Concept Registration Form and tick the appropriate box.

» NCRI Study Concept Registration Form (internal webpage)

The completed form will be sent to the Chair, who will essentially act as a ‘filter’ and send the trial query to a relevant member of the Advisory Group.

Should you require more generic advice, please contact the NCRI Advisory Group Coordinator.

» Email NCRI Advisory Groups

Other Information

The current annual report from the Molecular Biomarkers Advisory Group can be found below.

» NCRI Molecular Biomarkers Advisory Group – Annual Report 2015-16 (PDF)